December 2, 2024 02:40 PM EST

FDA defends increased use of guidance in new report to Congress

Zachary Brennan

Senior Editor

The FDA is defending its increased use of non-binding guidance documents rather than legally-enforceable rulemakings, arguing that guidance can better keep pace with the latest …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA defends increased use of guidance in new report to Congress

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Scott Gottlieb says he’s against RFK Jr. for HHS: ‘It will cost lives in this country’

Novartis pays $1B upfront for PTC's Phase 2 Huntington's drug

Apogee targets Dupixent head-to-head next year as it outlines broad pipeline plans

Novocure says electric field therapy extends life for pancreatic cancer patients by two months

Olema, Novartis ink another agreement, this time for a late-stage breast cancer trial

Sanofi earmarks €1B for new insulin production factory in Beijing

FDA de­fends in­creased use of guid­ance in new re­port to Con­gress

Zachary Brennan

Senior Editor

Sign up to read this article for free.

more like this

Scott Got­tlieb says he’s against RFK Jr. for HHS: ‘It will cost lives in this coun­try’

No­var­tis pays $1B up­front for PTC's Phase 2 Hunt­ing­ton's drug

Apogee tar­gets Dupix­ent head-to-head next year as it out­lines broad pipeline plans

Novo­cure says elec­tric field ther­a­py ex­tends life for pan­cre­at­ic can­cer pa­tients by two months

Ole­ma, No­var­tis ink an­oth­er agree­ment, this time for a late-stage breast can­cer tri­al

Sanofi ear­marks €1B for new in­sulin pro­duc­tion fac­to­ry in Bei­jing

FDA defends increased use of guidance in new report to Congress

Scott Gottlieb says he’s against RFK Jr. for HHS: ‘It will cost lives in this country’

Novartis pays $1B upfront for PTC's Phase 2 Huntington's drug

Apogee targets Dupixent head-to-head next year as it outlines broad pipeline plans

Novocure says electric field therapy extends life for pancreatic cancer patients by two months

Olema, Novartis ink another agreement, this time for a late-stage breast cancer trial

Sanofi earmarks €1B for new insulin production factory in Beijing